Cell and Gene Therapy 12/09/2019 60 Seconds with...Frances Pang, Orchard Therapeutics Frances Pang, VP Global Market Access at Orchard Therapeutics on evolving access and reimbursement structures, HTA engagement and commercial success
Cell and Gene Therapy 03/09/2019 60 Seconds with...Pilar Pinilla-Dominguez, NICE Pilar Pinilla-Dominguez, Senior Scientific Adviser at NICE on reimbursement models for advanced therapies
Cell and Gene Therapy 06/08/2019 Advanced Therapies Opportunities in Europe An overview of clinical, investment and market approval activity in Europe
Cell and Gene Therapy 01/08/2019 Translating Scientific and Technology Innovations from Academic... An unmissable interview with Dr Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of...
Cell and Gene Therapy 25/06/2019 Technology Review: Gene Editing Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where...
Cell and Gene Therapy 23/06/2019 Patient Access and Delivery of Advanced Therapies - Part Two An interview with Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine, Massachusetts General Hospital
Cell and Gene Therapy 30/05/2019 ASGCT 2019: Patients are Top Priority Amanda Kendall, Phacilitate's Head of Community, gives her first-hand account of ASGCT 2019
Cell and Gene Therapy 28/05/2019 Are We Ready for a $5m Gene Therapy? Episode two of the Phacilitate Leaders World super plenary sessions with Dave Lennon, President of AveXis, Inc
Cell and Gene Therapy 28/05/2019 Advanced Therapies: Cost-effective but Unaffordable? Episode three of the Phacilitate Leaders World super plenary sessions with Michael Meyers, Head of Investment Banking...
Cell and Gene Therapy 24/05/2019 Uncovering Innovation: Phacilitate’s Trip to Israel Phacilitate's Jeremy Roden and David Green ventured out to Tel Aviv to lift the lid on the biotech and advanced therapies innovation across the...
Cell and Gene Therapy 22/05/2019 Manufacturing Advanced Therapies in Europe A comprehensive guide and map showcasing Europe's growing cell and gene therapies and viral vector manufacturing landscape
Cell and Gene Therapy 20/05/2019 Five Take-aways from the Advanced Therapies Network Investment Event Phacilitate's Kim Barnes gives her account of the Advanced Therapies Network investment meeting in London
Cell and Gene Therapy 13/05/2019 60 seconds with...Jeff Robertson, Charter Medical Charter Medical's President on automation and tubing standardisation
Cell and Gene Therapy 08/05/2019 Patient Access and Delivery of Advanced Therapies - Part One An interview with Jacqueline Barry, Chief Clinical Officer at Cell and Gene Therapy Catapult
Cell and Gene Therapy 07/05/2019 60 seconds with...Philip Wills, Paragon Bioservices Paragon Bioservice's Chief Commercial Officer on being acquired by Catalent and the future of the contract manufacturing landscape
